Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome.

Wang L, Ma N, Okamoto S, Amaishi Y, Sato E, Seo N, Mineno J, Takesako K, Kato T, Shiku H.

Oncoimmunology. 2016 Jul 25;5(9):e1211218. eCollection 2016.

2.

Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer.

Kageyama S, Ikeda H, Miyahara Y, Imai N, Ishihara M, Saito K, Sugino S, Ueda S, Ishikawa T, Kokura S, Naota H, Ohishi K, Shiraishi T, Inoue N, Tanabe M, Kidokoro T, Yoshioka H, Tomura D, Nukaya I, Mineno J, Takesako K, Katayama N, Shiku H.

Clin Cancer Res. 2015 May 15;21(10):2268-77. doi: 10.1158/1078-0432.CCR-14-1559. Epub 2015 Apr 8.

3.

Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer.

Kasuya H, Kodera Y, Nakao A, Yamamura K, Gewen T, Zhiwen W, Hotta Y, Yamada S, Fujii T, Fukuda S, Tsurumaru N, Kuwahara T, Kikumori T, Koide Y, Fujimoto Y, Nakashima T, Hirooka Y, Shiku H, Tanaka M, Takesako K, Kondo T, Aleksic B, Kawashima H, Goto H, Nishiyama Y.

Hepatogastroenterology. 2014 May;61(131):599-605.

PMID:
26176043
4.

Stimulation through very late antigen-4 and -5 improves the multifunctionality and memory formation of CD8⁺ T cells.

Hosoi H, Ikeda H, Imai N, Amaike C, Wang L, Orito Y, Yamane M, Ueno H, Ideno M, Nukaya I, Enoki T, Mineno J, Takesako K, Hirano S, Shiku H.

Eur J Immunol. 2014 Jun;44(6):1747-58. doi: 10.1002/eji.201343969. Epub 2014 May 11.

5.

Development of medical communication support system "health life passport".

Takizawa K, Takesako K, Kawamura M, Sakamaki T.

Stud Health Technol Inform. 2013;192:1027.

PMID:
23920801
6.

CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models.

Tsukahara T, Ohmine K, Yamamoto C, Uchibori R, Ido H, Teruya T, Urabe M, Mizukami H, Kume A, Nakamura M, Mineno J, Takesako K, Riviere I, Sadelain M, Brentjens R, Ozawa K.

Biochem Biophys Res Commun. 2013 Aug 16;438(1):84-9. doi: 10.1016/j.bbrc.2013.07.030. Epub 2013 Jul 17.

7.

Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial.

Oshita C, Takikawa M, Kume A, Miyata H, Ashizawa T, Iizuka A, Kiyohara Y, Yoshikawa S, Tanosaki R, Yamazaki N, Yamamoto A, Takesako K, Yamaguchi K, Akiyama Y.

Oncol Rep. 2012 Oct;28(4):1131-8. doi: 10.3892/or.2012.1956. Epub 2012 Aug 7.

8.

T-cell receptor gene therapy targeting melanoma-associated antigen-A4 inhibits human tumor growth in non-obese diabetic/SCID/γcnull mice.

Shirakura Y, Mizuno Y, Wang L, Imai N, Amaike C, Sato E, Ito M, Nukaya I, Mineno J, Takesako K, Ikeda H, Shiku H.

Cancer Sci. 2012 Jan;103(1):17-25. doi: 10.1111/j.1349-7006.2011.02111.x. Epub 2011 Nov 8.

9.

[Adoptive immunotherapy for cancer with genetically engineered T cells].

Ikeda H, Okamoto S, Mineno J, Imai N, Ito M, Yasukawa M, Takesako K, Shiku H.

Rinsho Ketsueki. 2010 Nov;51(11):1647-53. Review. Japanese. No abstract available.

PMID:
21157127
10.

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells.

Akiyama Y, Tanosaki R, Inoue N, Shimada M, Hotate Y, Yamamoto A, Yamazaki N, Kawashima I, Nukaya I, Takesako K, Maruyama K, Takaue Y, Yamaguchi K.

J Transl Med. 2005 Jan 28;3(1):4.

11.

Recognition of Epstein-Barr virus-associated gastric carcinoma cells by cytotoxic T lymphocytes induced in vitro with autologous lymphoblastoid cell line and LMP2-derived, HLA-A24-restricted 9-mer peptide.

Okugawa K, Itoh T, Kawashima I, Takesako K, Mazda O, Nukaya I, Yano Y, Yamamoto Y, Yamagishi H, Ueda Y.

Oncol Rep. 2004 Oct;12(4):725-31.

PMID:
15375491
12.

Cytotoxic T cell induction against human malignant melanoma cells using HLA-A24-restricted melanoma peptide cocktail.

Akiyama Y, Maruyama K, Nara N, Mochizuki T, Yamamoto A, Yamazaki N, Kawashima I, Nukaya I, Takesako K, Yamaguchi K.

Anticancer Res. 2004 Mar-Apr;24(2B):571-7.

13.

Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.

Ueda Y, Itoh T, Nukaya I, Kawashima I, Okugawa K, Yano Y, Yamamoto Y, Naitoh K, Shimizu K, Imura K, Fuji N, Fujiwara H, Ochiai T, Itoi H, Sonoyama T, Hagiwara A, Takesako K, Yamagishi H.

Int J Oncol. 2004 Apr;24(4):909-17.

PMID:
15010829
14.

Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cells.

Matsuda K, Tsunoda T, Tanaka H, Umano Y, Tanimura H, Nukaya I, Takesako K, Yamaue H.

Cancer Immunol Immunother. 2004 Jul;53(7):609-16. Epub 2004 Jan 20.

PMID:
14735319
15.

A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo.

Ando Y, Haraoka K, Terazaki H, Tanoue Y, Ishikawa K, Katsuragi S, Nakamura M, Sun X, Nakagawa K, Sasamoto K, Takesako K, Ishizaki T, Sasaki Y, Doh-ura K.

Lab Invest. 2003 Dec;83(12):1751-9.

16.

Basic study of an agent for reinforcement of near-infrared fluorescence on tumor tissue.

Inayama K, Ito S, Muguruma N, Kusaka Y, Bando T, Tadatsu Y, Tadatsu M, Ii K, Shibamura S, Takesako K.

Dig Liver Dis. 2003 Feb;35(2):88-93.

PMID:
12747626
17.

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

Horiguchi Y, Nukaya I, Okazawa K, Kawashima I, Fikes J, Sette A, Tachibana M, Takesako K, Murai M.

Clin Cancer Res. 2002 Dec;8(12):3885-92.

18.

[Issues in the development of drugs for treating deep-seated mycosis].

Uchida K, Sawae Y, Takesako K, Hori Y, Ohya S, Yoshida M, Miyazaki Y, Matsumori H, Mizukane R, Kohno S, Yamaguchi H.

Nihon Ishinkin Gakkai Zasshi. 2002;43(4):239-47. Review. Japanese.

19.

[Analysis of IgE reactivities of purified allergens from Candida albicans and Malassezia furfur among patients with atopic dermatitis].

Asako Y, Saito A, Yasueda H, Kawaguchi H, Akiyama K, Endo M, Onishi Y, Takesako K.

Arerugi. 2002 Aug;51(8):615-21. Japanese.

PMID:
12368565
20.

Protection of mice from lethal endogenous Candida albicans infection by immunization with Candida membrane antigen.

Tansho S, Ab S, Mizutani S, Ono Y, Takesako K, Yamaguchi H.

Microbiol Immunol. 2002;46(5):307-11.

21.

Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy.

Bando T, Muguruma N, Ito S, Musashi Y, Inayama K, Kusaka Y, Tadatsu M, Kunio I, Irimura T, Shibamura S, Takesako K.

J Gastroenterol. 2002;37(4):260-9.

PMID:
11993509
22.

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen.

Itoh T, Ueda Y, Kawashima I, Nukaya I, Fujiwara H, Fuji N, Yamashita T, Yoshimura T, Okugawa K, Iwasaki T, Ideno M, Takesako K, Mitsuhashi M, Orita K, Yamagishi H.

Cancer Immunol Immunother. 2002 Apr;51(2):99-106. Epub 2002 Jan 30.

PMID:
11904734
23.

Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro.

Ito S, Muguruma N, Kusaka Y, Tadatsu M, Inayama K, Musashi Y, Yano M, Bando T, Honda H, Shimizu I, Ii K, Takesako K, Takeuchi H, Shibamura S.

Endoscopy. 2001 Oct;33(10):849-53.

PMID:
11571680
24.

Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas.

Sadanaga N, Nagashima H, Mashino K, Tahara K, Yamaguchi H, Ohta M, Fujie T, Tanaka F, Inoue H, Takesako K, Akiyoshi T, Mori M.

Clin Cancer Res. 2001 Aug;7(8):2277-84.

25.

Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide.

Nishiyama T, Tachibana M, Horiguchi Y, Nakamura K, Ikeda Y, Takesako K, Murai M.

Clin Cancer Res. 2001 Jan;7(1):23-31.

26.

Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas.

Tanaka H, Tsunoda T, Nukaya I, Sette A, Matsuda K, Umano Y, Yamaue H, Takesako K, Tanimura H.

Br J Cancer. 2001 Jan 5;84(1):94-9.

27.

CD4(+)-T-Cell-mediated resistance to systemic murine candidiasis induced by a membrane fraction of Candida albicans.

Mizutani S, Endo M, Ino-Ue T, Kurasawa M, Uno Y, Saito H, Onogi K, Kato I, Takesako K.

Antimicrob Agents Chemother. 2000 Oct;44(10):2653-8.

28.

Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.

Tiberghien F, Kurome T, Takesako K, Didier A, Wenandy T, Loor F.

J Med Chem. 2000 Jun 29;43(13):2547-56.

PMID:
10891114
29.

Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.

Mizutani S, Endo M, Ino-Ue T, Kurasawa M, Uno Y, Saito H, Kato I, Takesako K.

Antimicrob Agents Chemother. 2000 Feb;44(2):243-7.

30.

Identification of a MAGE-2-encoded human leukocyte antigen-A24-binding synthetic peptide that induces specific antitumor cytotoxic T lymphocytes.

Tahara K, Takesako K, Sette A, Celis E, Kitano S, Akiyoshi T.

Clin Cancer Res. 1999 Aug;5(8):2236-41.

31.

Labeled carcinoembryonic antigen antibodies excitable by infrared rays: a novel diagnostic method for micro cancers in the digestive tract.

Muguruma N, Ito S, Bando T, Taoka S, Kusaka Y, Hayashi S, Ichikawa S, Matsunaga Y, Tada Y, Okamura S, Ii K, Imaizumi K, Nakamura K, Takesako K, Shibamura S.

Intern Med. 1999 Jul;38(7):537-42.

32.

Generation of specific antitumor reactivity by the stimulation of spleen cells from gastric cancer patients with MAGE-3 synthetic peptide.

Fujie T, Tanaka F, Tahara K, Li J, Tanaka S, Mori M, Ueo H, Takesako K, Akiyoshi T.

Cancer Immunol Immunother. 1999 Jul;48(4):189-94.

PMID:
10431688
34.

Two-dimensional electrophoresis of Malassezia allergens for atopic dermatitis and isolation of Mal f 4 homologs with mitochondrial malate dehydrogenase.

Onishi Y, Kuroda M, Yasueda H, Saito A, Sono-Koyama E, Tunasawa S, Hashida-Okado T, Yagihara T, Uchida K, Yamaguchi H, Akiyama K, Kato I, Takesako K.

Eur J Biochem. 1999 Apr;261(1):148-54.

35.
36.

Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte.

Nukaya I, Yasumoto M, Iwasaki T, Ideno M, Sette A, Celis E, Takesako K, Kato I.

Int J Cancer. 1999 Jan 5;80(1):92-7.

37.

A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes.

Fujie T, Tahara K, Tanaka F, Mori M, Takesako K, Akiyoshi T.

Int J Cancer. 1999 Jan 18;80(2):169-72.

39.

Identification of radicicol as an inhibitor of in vivo Ras/Raf interaction with the yeast two-hybrid screening system.

Ki SW, Kasahara K, Kwon HJ, Eishima J, Takesako K, Cooper JA, Yoshida M, Horinouchi S.

J Antibiot (Tokyo). 1998 Oct;51(10):936-44.

40.
42.

Antibodies labeled with fluorescence-agent excitable by infrared rays.

Muguruma N, Ito S, Hayashi S, Taoka S, Kakehashi H, Ii K, Shibamura S, Takesako K.

J Gastroenterol. 1998 Aug;33(4):467-71. Erratum in: J Gastroenterol 1999 Oct;34(5):659.

PMID:
9719226
43.

Identification and cloning of two novel allergens from the lipophilic yeast, Malassezia furfur.

Yasueda H, Hashida-Okado T, Saito A, Uchida K, Kuroda M, Onishi Y, Takahashi K, Yamaguchi H, Takesako K, Akiyama K.

Biochem Biophys Res Commun. 1998 Jul 20;248(2):240-4.

PMID:
9675120
44.

Development of agents for reinforcement of fluorescence on near-infrared ray excitation for immunohistological staining.

Ito S, Muguruma N, Hayashi S, Taoka S, Bando T, Inayama K, Sogabe M, Okahisa T, Okamura S, Shibata H, Irimura T, Takesako K, Shibamura S.

Bioorg Med Chem. 1998 May;6(5):613-8.

PMID:
9629475
45.

Syntheses of antifungal aureobasidin A analogs with alkyl chains for structure-activity relationship.

Kurome T, Inoue T, Takesako K, Kato I.

J Antibiot (Tokyo). 1998 Mar;51(3):359-67.

46.

Aureobasidins as new inhibitors of P-glycoprotein in multidrug resistant tumor cells.

Kurome T, Takesako K, Kato I.

J Antibiot (Tokyo). 1998 Mar;51(3):353-8.

47.

Role of ABC transporters in aureobasidin A resistance.

Ogawa A, Hashida-Okado T, Endo M, Yoshioka H, Tsuruo T, Takesako K, Kato I.

Antimicrob Agents Chemother. 1998 Apr;42(4):755-61.

48.

The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

Kawashima I, Hudson SJ, Tsai V, Southwood S, Takesako K, Appella E, Sette A, Celis E.

Hum Immunol. 1998 Jan;59(1):1-14.

PMID:
9544234
49.

Transformation system for prototrophic industrial yeasts using the AUR1 gene as a dominant selection marker.

Hashida-Okado T, Ogawa A, Kato I, Takesako K.

FEBS Lett. 1998 Mar 20;425(1):117-22.

50.

Assay for detecting IgE and IgG antibodies against Candida albicans cell-wall mannan.

Akiyama K, Shida T, Yasueda H, Saito A, Hasegawa M, Maeda Y, Takesako K, Yamaguchi H, Kato H.

Allergy. 1998 Feb;53(2):173-9.

PMID:
9534916

Supplemental Content

Loading ...
Support Center